Last edition
News about Consultants
Consultants | 20/07/2023 | By Sudeep Soparkar | 567
PGWA to expand activities throughout the country to take up issues facing the pharmacy profession
The Pharmacy Graduates Welfare Association (PGWA), an organization of graduate pharmacists working under the Delhi government, is now chalking out an organizational expansion program to carry out across the country in the wake of multiple issues arising in various states with respect to the pharmacy profession and their welfare projects, it is learned
Consultants | 01/04/2022 | By Darshana | 778
The event brought together leaders from the industry, regulatory agencies, academia and subject experts from India and across the globe to facilitate discussions on Making quality pharmaceuticals in India, sustainably, for the World.
Consultants | 26/02/2022 | By Darshana | 615
The forum aims to bring manufacturers and regulators on a common platform to facilitate discussions resulting in meaningful and actionable outcomes in quality. The summit will feature more than 30 global leaders and regulators taking part in 15 sessions covering key aspects of manufacturing and quality with a view on sustainability
Consultants | 23/02/2022 | By Darshana | 547
This two-days event will focus on exploring pharma and healthcare industry current position and their future in light of novel approaches and capabilities beyond the pandemic. BioAsia 2022 platform will be shared by leaders from the industry, academia, and governments from more than 70 countries to address the wide-ranging needs of the healthcare system
Consultants | 21/02/2022 | By Darshana | 655
Future of pharma companies communication with doctors would be hybrid model: Survey
The future of pharmaceutical companies? communication with doctors would be a hybrid model of digital communication supported by physical connect, as almost 40 per cent of the doctors prefer the model, according to a recent survey on the trends in pharma communication post Covid-19 pandemic by Rediffusion Healthcare.
Consultants | 30/11/2021 | By Darshana | 523
Glenmark Pharmaceuticals makes it to DJSI for fourth consecutive year
Glenmark Pharmaceuticals today announced that the company has been listed in the Dow Jones Sustainability Index (DJSI) under the category of emerging markets for the fourth consecutive year, the company notified via a statement
Consultants | 17/11/2021 | By Darshana | 306
Fidelity Health Services to expand markets globally to offer pharmacovigilance services
Besides catering to five pharmaceutical companies and a few global CROs as their outsourcing partner for pharmacovigilance services, the company has been offering its end-to-end services for the last 5 years to one of the top generic pharmaceutical companies, empowering it to market highly valued products in 30 global markets
Consultants | 01/10/2021 | By Darshana | 612
TB Alliance and Lupin partner to manufacture anti-TB drug pretomanid
The TB Alliance has granted Lupin a non-exclusive license to manufacture the anti-TB drug pretomanid as part of the three-drug BPaL regimen. Lupin intends to commercialise the anti-tuberculosis (TB) medicine in approximately 140 countries and territories
Consultants | 07/09/2021 | By Darshana | 356
Centrient Pharmaceuticals completes acquisition of Astral SteriTech
With the addition of Astral SteriTech's semi-synthetic cephalosporin and semi-synthetic penicillin sterile injectable finished dosage forms to Centrient's product portfolio, the company can now further meet the needs of customers and reach more patients with its critical life-saving medicine
Consultants | 03/09/2021 | By Darshana | 674
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy